DataCloudKnowledgetrainingcoordination

Autoimmune Diseases (Disease Or Phenotype)

Omim:MTHU027840

Nci:C2889

Msh:D001327

Mondo:MONDO:7179

Medcin:MEDCIN:98338

Mdr:MDR:10061664

Id:7ecc6277-56d9-54ec-a9cb-2954b15d3e2b

Icpc2icd10eng:MTHU009485

Icd10cm:M30-M36

Efo:EFO:5809

Doid:DOID:417

Chv:CHV:1605

Results found

Linked to

	Label	Description
	methylprednisolone indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisone indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone hemisuccinate indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone acetate indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Autoimmune Diseases Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

methylprednisolone indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisone indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone hemisuccinate indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone acetate indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Autoimmune Diseases

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.